Latest News
Specific Biologics and Western University win grant to develop ML platform to accelerate development of Dualase-based therapeutics 
19 March 2026 - Canadian biotechnology company Specific Biologics Inc announced on Wednesday that together with Western University it has been awarded a grant of more than CAD1.8m from Genome Canada and Ontario Genomics Genomic Applications Partnersh...
Mabtech partners with Sai Life Sciences to expand access to EYRA multiplex immunology platform
19 March 2026 - Swedish life science tools company Mabtech announced on Wednesday a strategic collaboration with Sai Life Sciences, a global Contract Research Organisation (CRO).Under the agreement, Sai's Boston discovery laboratory will serve a...
IsomAb names new CEO
19 March 2026 - UK biotechnology company IsomAb Ltd announced on Wednesday the appointment of Dr Philip Brainin as chief executive officer and member of the board of directors.IsomAb is developing isoform-specific antibody therapeutics for atheroscle...
CVS Health announces quarterly dividend of USD0.665 per share
19 March 2026 - US healthcare company CVS Health (NYSE:CVS) announced on Wednesday a quarterly dividend of USD0.665 per share on its common stock.This amount is unchanged from the previous quarterly dividend.It will be paid on 4 March 2026 to shareho...
Elaris FlexCo signs global licence agreement with Valneva
19 March 2026 - Elaris FlexCo, an Austrian biotechnology company developing vaccines against serious bacterial infections, announced on Wednesday that it has signed a licensing agreement with French vaccine company Valneva SE (Nasdaq:VALN) (Euronext ...